Pyng Medical Corp. (TSX VENTURE:PYT) is pleased to announce it has engaged StarFish Medical to design and develop the next generation of the FAST1(TM) Intraosseous Infusion System. FAST1(TM) is the only intraosseous infusion device able to provide rapid sternal access and delivery of life saving fluids and drugs to the heart of critically injured patients in seconds. "Pyng is committed to advancing and expanding our family of intraosseous infusion systems to address our expanding critical care markets in military, hospital, and emergency medical services," stated David Christie, President and CEO of Pyng.
StarFish Medical are specialists in contract medical device development and manufacturing. For over 10 years StarFish Medical has designed, developed and manufactured sophisticated medical devices for a select clientele. StarFish, based in Victoria, BC, was chosen for their ability to provide turnkey medical device design solutions under their ISO 13485 Quality System, and their experience with precision mechanical parts and plastic materials.
"We are excited by the opportunity to continue our partnership with Pyng in developing the next generation FAST1(TM). This technology will position Pyng as the dominant provider of intraosseous infusion products," said Scott Phillips, President of StarFish Medical. |
